|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn679551807 |
003 |
OCoLC |
005 |
20231117044454.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
101108s1983 enka ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCF
|d N$T
|d E7B
|d YDXCP
|d EBLCP
|d HEBIS
|d OCLCQ
|d OCLCO
|d MERUC
|d OCLCO
|d STF
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d UKAHL
|d UAB
|d VLY
|d OCLCO
|d OCLCQ
|d OCL
|d SMC
|d OCLCO
|
066 |
|
|
|c (S
|
019 |
|
|
|a 664773017
|a 776876047
|a 896795363
|a 974617469
|a 1100972530
|a 1397390261
|
020 |
|
|
|a 9781483163673
|q (electronic bk.)
|
020 |
|
|
|a 1483163679
|q (electronic bk.)
|
020 |
|
|
|z 0408709502
|
020 |
|
|
|z 9780408709507
|
035 |
|
|
|a (OCoLC)679551807
|z (OCoLC)664773017
|z (OCoLC)776876047
|z (OCoLC)896795363
|z (OCoLC)974617469
|z (OCoLC)1100972530
|z (OCoLC)1397390261
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM301.7
|
060 |
|
4 |
|a QV 38
|b R519q 1983
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.19/00153012
|2 19
|
100 |
1 |
|
|a Richards, W. G.
|q (William Graham)
|
245 |
1 |
0 |
|a Quantum pharmacology /
|c W.G. Richards.
|
250 |
|
|
|a 2nd ed.
|
260 |
|
|
|a London ;
|a Boston :
|b Butterworths,
|c 1983.
|
300 |
|
|
|a 1 online resource (xiv, 273 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 243-268) and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Quantum Pharmacology; Copyright Page; Preface to second edition; Preface to first edition; Table of Contents; Introduction; Part I: Molecular pharmacology; Chapter 1. Small molecules in biology; Action Potentials; The classification of nerves; Neuron structure and junctions; Nerve transmitters; Synaptic actions of neuro-transmitters; Receptors; Summary; Further reading; Chapter 2. Quantitative pharmacology; Pharmacological measurements; Responses; Dose-response curves; Direct binding studies; Theories of drug action; Quantitative receptor theory; Some complications; Summary.
|
505 |
8 |
|
|6 880-01
|a Physiological and pathological effectsHistamine release; Pharmacological testing; Agonists; H1 Antagonists; H2 Antagonists; Summary; Further reading; Chapter 6. Central nervous system I. Monoamines and acetylcholine; Chemical transmitters; Catecholamines; Histamine; Acetylcholine; Central nervous system drugs; Antipsychotics; Antidepressants; Psychomotor stimulants; Hallucinogens; Further reading; Chapter 7. Central nervous system II. Amino acids and peptides; Amino acids; Anti-anxiety drugs; Anti-epileptic drugs; Peptides; Analgesics; Summary; Further reading; Chapter 8. Anaesthetics.
|
505 |
8 |
|
|a General anaestheticsTheories of general anaesthesia; Local anaesthetics; Summary; Further reading; Chapter 9. Chemotherapy; Sulphonamides; Antibiotics; Antimalarials; Antiviral agents; Cancer chemotherapy; Summary; Further reading; Chapter 10. Other areas; Kinins; Prostaglandins; Anti-inflammatory drugs; Hormones; Vitamins; Summary; Further reading; Part II: Molecular quantum mechanics; Chapter 11. Wave functions and orbitals; Wave functions; Orbitals; Spin-orbitals and antisymmetry; Molecular orbitals; Secular equations; Matrix elements; Self-consistent molecular orbitals.
|
505 |
8 |
|
|a Configuration interactionSummary; Further reading; Chapter 12. Approximate wave functions; Ab initio methods; Correlation energy; Semi-empirical calculations; Neglect of differential overlap; The use of localized orbitals; Use of an undefined hamiltonian operator; Computer programs for molecular orbital calculations; Summary; Further reading; Chapter 13. Calculated molecular properties; Energies; Molecular geometry; Conformation; Conformational free energies; Ionization potentials and electron affinities; Charge distribution; Mulliken population analysis; Molecular potential fields.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Quantum pharmacology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Quantum theory.
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
2 |
|a Quantum Theory
|0 (DNLM)D011789
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
6 |
|a Th�eorie quantique.
|0 (CaQQLa)201-0010146
|
650 |
|
6 |
|a Pharmacologie quantique.
|0 (CaQQLa)201-0080207
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Quantum theory
|2 fast
|0 (OCoLC)fst01085128
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
650 |
|
7 |
|a Quantum pharmacology
|2 fast
|0 (OCoLC)fst01085125
|
650 |
|
7 |
|a Pharmakologie
|2 gnd
|0 (DE-588)4045687-0
|
650 |
|
7 |
|a Quantentheorie
|2 gnd
|0 (DE-588)4047992-4
|
776 |
0 |
8 |
|i Print version:
|a Richards, W.G. (William Graham).
|t Quantum pharmacology.
|b 2nd ed.
|d London ; Boston : Butterworths, 1983
|w (OCoLC)11212947
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780408709507
|z Texto completo
|
880 |
8 |
|
|6 505-01/(S
|a Further readingChapter 3. Acetylcholine; Voluntary nerves: the neuromuscular junction; Autonomie ganglia; Post-ganglionic nerve endings; Anticholinesterases; Acetylcholine release; Isolation of acetylcholine receptors; Summary; Further reading; Chapter 4. Catecholamines; The classification of receptors; Pharmacological preparations; Agonists; α-Receptor antagonists; β-Receptor antagonists; The β-adrenergic receptor and adenylate cyclase activity; Blockage of release and uptake; Monoamine oxidase (MAO) inhibitors; Summary; Further reading; Chapter 5. Histamine; Occurrence.
|